{"nct_id":"NCT04659603","title":"Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2021-03-29","start_date_type":"ACTUAL","primary_completion_date":"2024-02-16","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}